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PURPOSE. We investigated whether fundus autofluorescence (FAF) lifetimes in patients with
retinitis pigmentosa display a disease-specific lifetime pattern.
METHODS. Fundus autofluorescence lifetime imaging ophthalmoscopy (FLIO) was performed
in two spectral channels (498–560 and 560–720 nm) after excitation with a 473 nm pulsed
laser in patients with retinitis pigmentosa and compared to healthy controls of a similar age
range. Corresponding FAF intensity and spectral domain optical coherence tomography
(OCT) data, as well as best corrected visual acuity (BCVA) were acquired and compared to
fluorescence lifetime data.
RESULTS. We investigated 43 eyes from 43 patients with retinitis pigmentosa (mean age 45 6
15 years) and compared them to eyes of 13 age-matched healthy participants. Mean FAF
lifetimes were prolonged in areas of photoreceptor atrophy with preserved retinal pigment
epithelium (RPE) (P ¼ 0.0036) and even longer in areas with total atrophy of photoreceptors
and RPE (P ¼ 0.0002). The prevalence of perifoveal ring structures characterized by
prolonged fluorescence lifetimes in FLIO was higher (63% vs. 49%) and the rings were wider
compared to the hyperautofluorescent rings in qualitative fundus autofluorescence intensity
images. In the central fovea with intact retinal layer structure identified by OCT, fluorescence
lifetimes were slightly prolonged compared to those of age-matched healthy controls (short
spectral channel [SSC], P ¼ 0.0044; long spectral channel [LSC], P ¼ 0.0128). Short lifetimes
within the macular center were negatively correlated with BCVA (R2 ¼ 0.33, P < 0.0001) as
well as the greatest diameter of the ellipsoid band in OCT.
CONCLUSIONS. FLIO in retinitis pigmentosa reveals characteristic patterns that allow
identification of areas of photoreceptor atrophy, RPE atrophy, and remaining photoreceptor
segments in areas of RPE atrophy. Fluorescence lifetimes can be used to identify ellipsoid zone
loss that correlates with functional parameters.
Keywords: fluorescence lifetimes, fundus autofluorescence, retinal imaging, FLIO, retinitis
pigmentosa, RP, retinal dystrophies, photoreceptor cells, optical coherence tomography,
retinal pigment epithelium, scanning laser ophthalmoscope
Retinitis pigmentosa (RP) is a genetically heterogeneousdegenerative retinal disease that leads to night blindness
and a progressive constriction of the visual field from the
periphery to the center. In the end stages, it can result in
blindness.1 RP may be inherited in an autosomal recessive or
dominant pattern as well as in an X-linked form. Clinically, bone
spicules in the retinal periphery may be seen, as well as general
thinning of the retina and attenuation of retinal vessels. These
findings are consistent with retinal degeneration and migration
of the RPE into the inner layers of the retina.
Functionally, rods are affected first at disease onset, although
with disease progression cones also become affected by a so-
called bystander effect and a generalized retinal dysfunction
eventually occurs.2 In a subset of RP patients, short wavelength
autofluorescence imaging (SW-AF, excitation at 486 nm) reveals a
hyperautofluorescent ring.3 It has been shown that the photore-
ceptor-attributed layers inside the outer border of this ring is
relatively preserved while outside of the outer border of the ring,
thinning of the photoreceptor layers with loss of the ellipsoid zone
(EZ) and external limiting membrane, and thinning or even
absence of the outer nuclear layer may be observed.4 Correlation
with optical coherence tomography (OCT) showed that SW-AF
rings demarcate the termination of the EZ of the photoreceptors.5
Melanin-based infrared (IR) fundus autofluorescence (FAF)
imaging also revealed hyperautofluorescent rings located on the
outermost border of the SW-AF ring. As the rings coincide with a
loss of the hyperreflective inner segment/outer segment (IS/OS)
band in OCT, increased photoreceptor phagocytosis has been
suggested.6–9 However, studies including photoreceptor bleach-
ing protocols, as well as studies of the Royal College of Surgeons
(RCS) in rat showed that bisretinoid fluorophore formation occurs
in photoreceptor cells before outer segment shedding and
subsequent phagocytosis.10,11 In addition to photoreceptor
degeneration, thinning of the RPE has been observed external of
the ring with more centripetal areas showing chorioretinal
atrophy and RPE migration into the inner retinal layers.
Fluorescence lifetime imaging ophthalmoscopy (FLIO) is a
novel method to topographically characterize lifetimes of
fluorophores in the retina.12–22 The fluorescence lifetime
represents the time that a fluorophore spends in its stimulated
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state upon excitation until the emission of a photon when
returning to the ground state.23 The ability of FLIO to identify
fluorophores deriving from the photoreceptor layer has been
described previously.23 The aim of this study was to
characterize fluorescence lifetime patterns in RP, and to
investigate whether fluorescence lifetimes provide additional
contrast to identify SW-AF rings and remaining photoreceptors
in areas of EZ loss in patients with RP.
METHODS
Subjects and Procedures
All subjects were recruited prospectively at the outpatient
department of ophthalmology of the University Hospital in
Bern, Switzerland and informed consent was signed before
study entry. This study followed the International Ethical
Guidelines for Biomedical Research involving Human Subjects
and is in accordance with the Declaration of Helsinki. The
study has been approved by the local ethics committee and
registered at ClinicalTrials.gov (NCT01981148). The genetic
background of the patients was assessed by a geneticist.
Reported family history was recorded and genetic testing was
performed whenever permitted by the health insurer.
The routine ophthalmic examination of all participants
included assessment of best corrected visual acuity (BCVA;
Early Treatment Diabetic Retinopathy Study [ETDRS] letters),24
measurement of the intraocular pressure by air tonometry,
maximal pupil dilation with tropicamide 0.5% and phenyleph-
rine hydrochloride 2.5%, followed by a general ophthalmic
examination. The diagnosis of RP was based on the classical
triad of retinal pigmentary changes in the midperiphery
(hypopigmentation and/or hyperpigmentation in form of
pigment clumpings or bone spicules), arteriolar attenuation,
and waxy disc pallor. The diagnosis was confirmed using
multimodal imaging, visual field testing, full field electroreti-
nography (ffERG) if available, and genetic family history.
Genetic testing was done whenever permitted by the health
insurer. All findings were documented by color fundus images
(Zeiss FF 450plus; Zeiss, Oberkochen, Germany), OCT, and FAF
imaging (Heidelberg Spectralis HRAþOCT; Heidelberg Engi-
neering, Heidelberg, Germany). Eyes with significant lens
opacities, such as subcapsular cataract as seen in up to 41% of
TABLE 1. Patient Characteristics and Inheritance Patterns
RP Control
Demographics
Number 43 13
Female/male 15/28 7/6
Age, mean 6 SD 44.5 6 15.3 44.5 6 15.4
Age range 18–76 24–61
Eyes
Study eye 22 (51%) right eye —
Pseudophakic 8 (18.6%) 0
VA, mean 6 SD 60.6 6 27.8 (4.2) ‡85
VA range 0–87 ‡85
Inheritance pattern
X-RP 2 (includes RPGR) —
AD-RP 10 —
AR-RP 28 (includes USH2A, MYO7A,
CNGB1, PRPF31, ABCA4)
—
Unknown 3 —
VA, visual acuity in ETDRS letters; X-RP, X-linked RP; AD/AR,
autosomal dominant/recessive; SD, standard deviation.
FIGURE 1. FLIO in different stages of RP. Qualitative FAF intensity and
FLIO images are shown for five RP patients (sex, female [f]/male [m];
age in years [y]; and BCVA [number of ETDRS letters; L] are indicated).
FLIO LSC ¼ 560–720 nm; color scale: 200–1000 picoseconds (ps).
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FIGURE 2. Fluorescence lifetime values in the macular center. (A) Qualitative FAF intensity and autofluorescence lifetime images are shown for a
patient with RP (above) and a healthy subject (below; FLIO LSC: color range, 200–1000 ps). Corresponding fluorescence decay curves of specific
locations are shown besides (Nr 1–4; blue dots, measured decay trace; red line, fitting curve; green line, instrument response function). Mean
fluorescence lifetime data was averaged in the indicated field C within the macular center (diameter ¼ 1 mm). (B) Comparison of the mean
autofluorescence lifetime within the central ETDRS subfield (C) in healthy control eyes and in RP patients. Lifetimes are significantly prolonged in
RP. (C) Correlation of FLIO with BCVA. A correlation index of R2 ¼ 0.33 (P > 0.0001) was measured.
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RP patients,25 were excluded from this study. Also, eyes with
ophthalmic conditions other than RP, such as corneal or other
retinal diseases were excluded. Both eyes of every participant
were investigated by FLIO, but only the eye with the better
image quality was analyzed further. If both eyes showed the
same image quality, one eye was chosen randomly to achieve
an equal distribution between both eyes.
Fluorescence Lifetime Imaging Ophthalmoscope
A fluorescence lifetime imaging ophthalmoscope was used for
excitation of retinal autofluorescence at 473 nm wavelength.
Corresponding decay times of the emitted fluorescence was
recorded in a short (498–560 nm, SSC) and a long (560–720
nm, LSC) spectral channel. The FLIO device is based on a
Heidelberg retina angiograph (HRA) Spectralis system (Heidel-
berg Engineering).
Detailed description of the FLIO technique and the
corresponding laser safety calculations have been reported
previously.13,16,26
A standard 308 FLIO image of the central fundus was
performed (256 3 256 pixels). The acquisition time per eye
was approximately 90 to 120 seconds for a minimal count of
1000 photons per pixel in the macular center. During this scan
duration, eye movement was recorded by an inbuilt infrared
camera to verify that every emitted fluorescence photon is
recorded at the correct location on the FLIO lifetime map.
Fluorescence photons were detected by highly sensitive hybrid
photon-counting detectors (HPM-100-40; Becker & Hickl,
Berlin, Germany) and registered by time-correlated single-
photon counting (TCSPC) modules (SPC-150; Becker & Hickl).
Mapping of all detected photons for every single pixel location
resulted in a qualitative FAF intensity image depicting the
relative intensity distribution over the investigated field of
view. By analyzing the exact photon count per pixel, also
quantitative statements may be possible.
Fluorescence Lifetime Data Analysis
In both wavelength channels, a decay trace of the recorded
photons after fluorescence excitation was calculated for each
pixel and a double exponential decay trace was approximated
using SPCImage 4.6 software (Becker & Hickl). This procedure
resulted in short and long decay times (T1 and T2) with their
respective intensities (amplitudes) a1 and a2. With the
following equation, the amplitude weighted mean fluores-
cence lifetime (Tm) was evaluated:
Tm ¼ a1T1 þ a2T2
a1 þ a2 ð1Þ
The purpose built ‘‘FLIO reader’’ software (ARTORG Center
for Biomedical Engineering Research, University of Bern, Bern,
Switzerland) was applied to average the assessed FLIO
parameters within the fields of a standard ETDRS grid with
circle diameters of 1 mm for the central area (C), 3 mm for the
inner ring (IR), and 6 mm for the outer ring (OR).13
To investigate specific regions of interest (ROI) within SW-
AF rings, sampling areas with a diameter of 1 mm were defined
within the temporal sector of the ETDRS grid.
Statistical Analysis
Mean values 6 SEM were published. GraphPad Prism version 6
(GraphPad Software, Inc., La Jolla, CA, USA) was used for
statistical data analysis. Results with P values below 0.05 were
considered statistically significant. If data were normally
distributed due to the D’Agostino and Pearson omnibus
normality test, data were compared using a 2-tailed t-test with
a confidence interval of 95%. For nonparametric data, Wilcoxon
matched pairs test was applied.
RESULTS
We investigated 43 patients with RP and compared them to data
of 13 age-matched healthy controls. Patients’ characteristics,
reported family history, visual acuity, and morphological data are
summarized in Table 1. Inheritance patterns were identifiable in
93% of the patients and genetic testing was performed in seven
patients (16%). The results included mutations in the following
genes: RPGR, USH2A, MYO7A, CNGB1, PRPF31, ABCA4.
Various patterns of RP and stages of degeneration were observed
in our cohort (Fig. 1).
Fluorescence Lifetimes Within the Macular Center
in RP Patients and Healthy Controls
In control eyes as well as in RP patients, the shortest
fluorescence lifetimes were measured within the macular center
(Fig. 1). The short lifetimes in the fovea have been attributed to
the presence of macular pigment.20 However, in RP patients,
mean fluorescence lifetimes in the central subfield of the ETDRS
grid were significantly prolonged compared to control eyes
(SSC, P¼ 0.0044; LSC, P¼ 0.0128; Figs. 2A, 2B; Table 2). There
was considerable variation in fluorescence lifetimes within the
central subfield in RP patients. This most likely was due to the
various stages of RP observed in our cohort as supported by the
large variation of BCVA and the different morphologic and
clinical appearance as exemplary shown in Figure 1. The mean
fluorescence lifetime in the macular center correlated negatively
with the BCVA (LSC, R2 ¼ 0.33, P < 0.0001; Fig. 2C).
TABLE 2. Fluorescence Lifetime Analysis in Specific Locations
Center Outer ETDRS Ring
Control RP
P
Value Control
RP: PR þ RPE
Intact
P
Value
RP: PR
Atrophy
P
Value
RP: PR þ RPE
Atrophy
P
Value
Short spectral channel, 498–560 nm
Mean 166.1 233.6 0.0056 262.8 259.3 NS 264.3 NS 374.0 0.0016
SEM 8.0 12.4 4.9 22.6 6.6 20.9
Coefficient of variation 17.4% 35.2% 6.4% 26.2% 12.5% 19.4%
Long spectral channel, 560–720 nm
Mean 234.6 297.0 0.0165 300.6 275.1 NS 306.9 0.0356 418.3 0.0002
SEM 4.6 13.6 4.4 13.8 7.2 24.5
Coefficient of variation 7% 30.3% 5.2% 15.1% 11.7 20.3%
RP, retinitis pigmentosa; PR, photoreceptor; RPE, retinal pigment epithelium.
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A subgroup analysis of RP patients with apparently
unsuspicious retinas within the central subfield of the ETDRS
grid as assessed by OCT and qualitative FAF intensity images
already revealed significantly prolonged fluorescence lifetimes
in both spectral channels compared to the cohort of healthy
participants (SSC, þ53.8 6 19.8 ps; LSC, þ39.4 6 16.7 ps).
Spatial Distribution of Fluorescence Lifetimes in
RP Patients and Healthy Controls
The spatial distribution of fluorescence lifetimes in the fundus
of healthy eyes showed a characteristic pattern where lifetimes
became gradually longer from the foveal center to the outer
FIGURE 3. Fluorescence lifetime values in the temporal retina. (A) Qualitative FAF intensity and autofluorescence lifetime images (FLIO LSC; color
range, 200–1000 ps) and OCT section (indicated location in FAF images) are shown. A schematic illustration represents the areas of analysis (ROI,
diameter 1 mm) within the temporal sector of the ETDRS grid. (A1) ROI with intact RPE and photoreceptors (PR). (A2) PR atrophy, RPE intact. (A3)
PR and RPE atrophy. (B) Mean fluorescence lifetime values within ROI (A1–A3) and healthy control eyes. RP, retinitis pigmentosa; PR,
photoreceptor; RPE, retinal pigment epithelium.
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ring of the ETDRS grid as described previously.13 In patients
with RP, the mean fluorescence lifetime also increased toward
the retinal periphery (Fig. 3). In the outer ring, mean
fluorescence lifetimes were longer in RP patients compared
to the controls (SSC, P¼ 0.05; LSC, P¼ 0.03). Detailed analysis
of the outer ETDRS ring in control and RP eyes revealed the
shortest lifetimes within the temporal grid area, followed by
the superior and inferior fields, and the longest lifetimes were
recorded within the nasal subfield.
Analysis of ROI
In areas of structurally unaffected retina within the outer
ETDRS ring, fluorescence lifetime values were comparable
between RP patients and healthy controls (SSC, P¼ 0.96; LSC,
P ¼ 0.63; Figs. 3A1, 3B; Table 2). Three different stages of
retinal atrophy and degeneration were identified outside the
SW-AF-rings: (1) Primarily loss of photoreceptors with pre-
served RPE in OCT resulted in significantly prolonged
fluorescence lifetimes of approximately 264 and 307 ps in
the SSC and LSC, respectively (P¼0.0356, Figs. 3A2, 4A). (2) In
the absence of RPE and photoreceptors, fluorescence lifetimes
were much longer, displaying values of approximately 374 and
418 ps in the SSC and LSC (P ¼ 0.0002, Fig. 3A3). In cases of
advanced complete chorioretinal atrophy, very long fluores-
cence lifetimes of over 1000 ps could be observed. However, if
these atrophic areas with long lifetimes involved the macular
center, a characteristic pattern with short components could
be identified, probably reflecting areas of dispersed macular
pigment. (3) In areas of RPE atrophy but remaining parts of the
photoreceptor layers, intermediate lifetime values were mea-
sured (Fig. 4B).
Perifoveal Ring Structures in RP
Areas with perifoveal concentrically ring- or crescent ring–
shaped increased autofluorescence intensity with absence of
the photoreceptor outer segments, but an intact outer nuclear
layer, showed prolonged fluorescence lifetimes measured in
the temporal sector (Fig. 5). In a cross-sectional profile through
the lifetime map, the ring-shaped prolonged mean fluores-
cence lifetimes in RP as well as the decreased short central
fluorescence lifetimes was clearly visible (Fig. 4A).
When analyzing qualitative autofluorescence intensity
images, in 13 patients (30%) a clear perifoveal hyperautofluor-
escent ring was identifiable (Table 3, Fig. 5). In 19%, this ring
was barely visible in SW-AF and in 51% it was not detectable at
all, partly also due to advanced stages of disease with
peripheral retinal atrophy. Among the autofluorescence
lifetime images, a perifoveal ring structure with prolonged
fluorescence lifetimes was clearly visible in 49%, faintly visible
in 14%, and not detectable in 37%. Thereby, in all cases of rings
in the SW-AF intensity images, the rings also were visible in the
lifetime map. However, in six cases, ring structures with
prolonged fluorescence lifetimes were identified in the FLIO
images, but were not visible in the qualitative autofluorescence
intensity images (for example see Fig. 1, Patient 1). All cases of
faintly visible rings in SW-AF images showed clear evidence of
rings in the FLIO measurement.
The width of the ring was measured in SW-AF as well as
FLIO images in the temporal ETDRS grid area. In all cases, the
ring with prolonged fluorescence lifetimes in the FLIO
measurement was broader (mean 6 SEM, 1.02 6 0.12 mm),
than the hyperautofluorescent ring in SW-AF (0.48 6 0.06 mm;
P ¼ 0.0007). The mean difference was 0.72 6 0.14 mm.
Thereby, the hyperautofluorescent ring was always identified
at the most centrally located part of the FLIO images (Fig. 5A).
The central area of qualitatively normal autofluorescence
intensity and normal fluorescence lifetimes corresponded to
the extent of the EZ in OCT. In OCT scans, the internal edge of
the hyperfluorescent ring in the qualitative autofluorescence
intensity image corresponded to the eccentric position at
which the hyperreflective band in OCT attributable to the
inner segment EZ was no longer intact. The mean fluorescence
FIGURE 4. Fluorescence lifetimes in areas with RPE atrophy. (A) Left
eye of a patient with peripheral atrophy of the photoreceptors but still
remaining RPE (red arrows). These areas feature slightly prolonged
autofluorescence lifetimes. (B) Left eye of a patient with central RPE
island with short autofluorescence lifetimes. In the temporal superior
area, intermediate lifetime values are measured, correlating to patchy
remaining RPE and photoreceptor islands in the OCT. In comparison,
areas of total RPE loss and photoreceptor atrophy (nasal and inferior)
feature long fluorescence lifetimes (Tm LSC, 560–720 nm; color range,
200–1000 ps).
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lifetime of the central subfield in the LSC correlated with the
extent of the EZ in OCT (Fig. 5B).
Analysis of Individual Fluorescence Lifetime
Components
As described in the Methods section, the mean fluorescence
lifetime represents the amplitude-weighted value of the short
and the long decay components resulting from the bi-
exponential fluorescence decay model (Equation 1). Each
lifetime value was represented within a two-dimensional
histogram of these two decay components (Fig. 6). The
resulting lifetime clusters allowed identifying and highlighting
specific retinal areas. Thereby, the fovea featured the shortest
T1, combined with short T2 values. In the morphologically
unaffected retina, short T2 were measured; however, the T1
values were slightly longer. The lifetime cloud of areas with
photoreceptor atrophy only was shifted mainly toward longer
T1 values, whereas in combined atrophy of the photoreceptors
and the RPE, T2 was clearly prolonged, resulting in long mean
fluorescence lifetimes. The optic nerve head featured long T2
values.
DISCUSSION
Retinal autofluorescence lifetime imaging in patients with RP
revealed specific lifetime distributions depending on the stage
of disease and correlating with BCVA and OCT measurements.
Fluorescence lifetimes in areas of photoreceptor atrophy were
FIGURE 5. (A) Ring structures in RP. Color fundus (CF), IR, qualitative FAF intensity, OCT (scale bar: 200 lm) of the indicated green line in FAF, IR,
and FLIO, and mean fluorescence lifetime images (FLIO; Tm LSC, 560–720 nm; color range 200–1000 ps). Black lines show borders of the intact
RPE and photoreceptors (PR) (1). White lines indicate the outer borders of persisting outer nuclear layer (2). Note that the hyperfluorescent ring in
FAF is much smaller than the ring of prolonged fluorescence lifetimes in FLIO. (B) The mean fluorescence lifetime of the central ETDRS grid subfield
(LSC) negatively correlated with the diameter of the area of preserved ellipsoid zone in OCT. (C) Lifetime distribution in the macular center in RP
(red line) and control images (green line) with corresponding OCT. RP patients show a decreased central peak and typically prolonged lifetimes in
the area of the ring structures. ONH, optic nerve head.
TABLE 3. Perifoveal Ring Structure in RP in Qualitative Fundus Autofluorescence Intensity and Lifetime Images
Ring Structure Clear Faintly Visible Not Visible Ring Width Temporal Ring Width SEM
Intensity image 13, 30% 8, 19% 22, 51% 0.48 mm 0.063 mm
Lifetime image 21, 49% 6, 14% 16, 37% 1.02 mm 0.123 mm
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slightly prolonged, and in case of combined photoreceptor and
RPE atrophy they were massively prolonged.
In RP, there typically is an initial degeneration of the rods
in the peripheral retina moving centripetally with subsequent
degeneration of cones.27 The co-dependence between cones
and rods is thought to lead to degeneration of cones in the
later stages of the disease.28 In keeping with the preponder-
ance of rod atrophy, the majority of the RP genes are
expressed in rods.29 Usually, the inner nuclear and ganglion
cell layers are well preserved in early stages of the disease, but
FIGURE 6. Analysis of individual lifetime components and spatial distribution in patients with RP. (A, B) Distribution histograms of the short lifetime
component T1 versus the long decay component T2 are shown (see also Equation 1) in the upper left with corresponding mean fluorescence
lifetime images (Tm, LSC). The circles in the two-dimensional plots demarcate lifetime clusters corresponding to specific retinal areas in the FLIO
image as depicted in the respectively color-framed qualitative FAF intensity images. (A) 1, fovea (red); 2, optic nerve head (blue); 3, main unaffected
retina (orange); 4, photoreceptor atrophy (yellow). (B) 1, central retina (yellow); 2, atrophic areas (blue). (C) Schematic drawing of a generalized
distribution histogram with specific areas color coded and labeled in the Figure.
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degenerate later.30 In the late stages, atrophy of the
underlying RPE follows photoreceptor atrophy, which moves
progressively toward the macula.31 In addition, aberrant
aggregation of melanin-containing cells appears in the mid
and far periphery representing the clinically visible bone
spicules. The different stages of atrophy can be differentiated
with OCT and FLIO. In areas of advanced atrophy (of
photoreceptors and RPE with increased transmission of the
OCT signal to the choroid) and thinned choriocapillary layer,
massively prolonged autofluorescence lifetimes are measured.
This is in keeping with previously reported data in patients
with choroideremia and geographic atrophy, where lifetimes
were prolonged as well in areas of RPE and photoreceptor
atrophy.14,17 In the area of preserved RPE, but thinned retina
outside of the hyperautofluorescent ring, corresponding to a
loss of EZ on OCT where there was no increased transmission
to the choriocapillaris,31 in our study shorter fluorescence
lifetimes were measured than in areas of complete chorioret-
inal atrophy. These values directly outside of the ring were
slightly longer than the lifetimes directly inside of the
hyperautofluorescent ring (Fig. 5C). Although the measured
ETDRS ring values in this area outside of the ring were
statistically longer compared to those inside of the ring, they
were not significantly longer than those of healthy controls
(Fig. 3B). Therefore, the signal in this area might be relatively
increased, since the fluorescence lifetime contributing
photoreceptors are degenerated, leaving a thinned RPE
overloaded with bisretinoid fluorophores that might further
contribute to retinal degeneration. Interestingly, in quantita-
tive autofluorescence (qAF), similar results were found, with
qAF levels outside of the rings being within the range of those
in healthy individuals, and lower than inside of the FAF ring.11
Similar to AMD, short fluorescence lifetimes in atrophic areas
in the central ETDRS subfield might reflect residual macular
pigment. However, in areas of RPE atrophy but partially
preserved photoreceptor segments, intermediate fluores-
cence lifetimes can be detected, allowing easy identification
of such areas. This finding confirms results of a previous study
in choroideremia patients, where areas of preserved photo-
receptors and concomitant RPE loss displayed significantly
shorter lifetimes than areas with loss of photoreceptors and
loss of RPE.18
In autofluorescence intensity images, a ring or arc of high
autofluorescence often is visible. The hyperautofluorescent
ring represents the transitional zone between degenerated and
intact photoreceptor cells.4,32,33 The inner border of the ring
delineates the retinal area with preserved visual function and
an intact hyperreflective band corresponding to the EZ on
OCT.4 Previous studies have shown that the extent of the ring
corresponds to visual field function and that rings may
constrict gradually over time.7,34 This ring is identifiable in
FLIO measurements and shows prolonged fluorescence
lifetimes. Our data shows that FLIO is sensitive to find and
detect such rings. Interestingly, the width of the rings
measured in FLIO images was approximately twice as broad
as measured in the short wavelengths autofluorescence image.
Typically, RP patients report persisting tunnel vision with
preserved central visual acuity in advanced stages as the
disease primarily affects the rod system. In areas of
apparently normal retinal structure in OCT within the outer
ring of the ETDRS grid, similar autofluorescence lifetime
values were measured compared to those in age-matched
healthy control subjects. However, interestingly, in our
study, retinal lifetimes within the macular center already
were prolonged compared to those in the control eyes even
if only RP patients without central structural changes in
OCT were analyzed. As RP not only affects rods, but also
cones,2 it remains to be seen whether FLIO is able to detect
early signs of involvement of the cone system. Alternatively,
as the retinal lifetimes within the fovea are attributed to the
presence and distribution of the macular pigment,20 the
question arises whether there is a change in the distribution
of the macular pigment in early forms of RP where the
central vision is not yet affected. Measured over all patients,
a correlation between vision and mean fluorescence lifetime
in the macular center was measured, whereby short values
were associated with better visual acuity.
By plotting individual lifetime components, such as T1 and
T2, against each other (Fig. 6), specific retinal areas, such as
the optic nerve or fovea can be identified.13,15 In addition,
areas with atrophy can be visualized. This tool may be used for
quantification of atrophic changes in follow-up examinations
and longitudinal studies.
Thereby, the FLIO technique in general may be helpful to
detect, quantify, and follow early and subtle retinal changes in
patients with RP. This might be particularly interesting in view
of new drug development (e.g., deuterated vitamin A) and
gene replacement therapies.
However, this study has some limitations. First of all, this
was a heterogeneous group of patients, including various
stages of disease and, therefore, large variability. Additionally,
genetic testing was performed in only a few patients due to
regulatory/governmental restrictions. Furthermore, only the
eye with the better image quality was chosen and, therefore, a
selection bias cannot be ruled out. As in other imaging
modalities, precise spatial localization and correlation with
retinal function is difficult and we did not perform micro-
perimetry in our patient cohort. As RP is a very slowly
progressing disease, follow-up data are still needed to search
for and identify markers for disease progression. A larger
cohort with genetic characterization and longitudinal evalua-
tion might reveal further insight into the pathogenesis of the
disease.
CONCLUSIONS
FLIO combined with qualitative autofluorescence intensity
measurements provides a tool for visualization of specific
retinal features, such as the RPE and photoreceptor integrity.
Thereby fluorescence lifetimes can be analyzed and compared
qualitatively by investigating the map of fluorescence lifetime
distribution, quantitatively by comparing specific lifetime
values, within fluorescence decay histograms among subjects,
and within follow-up examinations. FLIO in RP potentially
provides information about the integrity and function of the
outer retinal layers.
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